购物车
您的购物车当前为空
BNC-101 是一种针对富含亮氨酸重复序列的 G 蛋白偶联受体 5 (LGR5/GPR49) 的人源化单克隆抗体。LGR5 是 Wnt 信号通路的关键组分,也是多种癌症(尤其是结直肠癌和胰腺癌)中癌症干细胞 (CSC) 的重要标志物。BNC-101 能以高亲和力特异性结合 LGR5 的胞外结构域,通过阻断 LGR5 与其配体 R-spondins 的结合,抑制 Wnt/beta-catenin 信号通路的异常激活。该抗体旨在通过靶向并消除 LGR5 阳性的癌症干细胞,降低肿瘤的成瘤性、复发率和转移潜力。
BNC-101 是一种针对富含亮氨酸重复序列的 G 蛋白偶联受体 5 (LGR5/GPR49) 的人源化单克隆抗体。LGR5 是 Wnt 信号通路的关键组分,也是多种癌症(尤其是结直肠癌和胰腺癌)中癌症干细胞 (CSC) 的重要标志物。BNC-101 能以高亲和力特异性结合 LGR5 的胞外结构域,通过阻断 LGR5 与其配体 R-spondins 的结合,抑制 Wnt/beta-catenin 信号通路的异常激活。该抗体旨在通过靶向并消除 LGR5 阳性的癌症干细胞,降低肿瘤的成瘤性、复发率和转移潜力。

| 产品描述 | BNC-101 is a humanized monoclonal antibody targeting Leucine-rich repeat-containing G-protein coupled receptor 5 (LGR5/GPR49). LGR5 is a key component of the Wnt signaling pathway and a critical marker of cancer stem cells (CSCs) in various malignancies, particularly colorectal and pancreatic cancers. BNC-101 binds specifically to the extracellular domain of LGR5 with high affinity, inhibiting the abnormal activation of the Wnt/beta-catenin signaling pathway by blocking the interaction between LGR5 and its ligands, R-spondins. This antibody is designed to reduce tumor tumorigenicity, recurrence, and metastatic potential by targeting and eliminating LGR5-positive cancer stem cells. |
| 反应种属 | Human |
| 应用 | ELISA FACS Functional assay |
| 抗体种类 | Monoclonal |
| 缓冲液 | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| 内毒素 | <1.0 EU/mg |
| 同型 | IgG1 |
| 偶联 | Unconjugated |
| Uniprot ID | |
| 靶点 | GPR49/LGR5 |
| 存储 |
对于不同动物的给药剂量换算,您也可以参考 更多